Diagnostic and Severity-Tracking Biomarkers for Autism Spectrum Disorder

[1]  F. De Luca.  Endocrinological Abnormalities in Autism. , 2016, Seminars in pediatric neurology.

[2]  M. Chartrand,et al.  How important is tryptophan in human health? , 2019, Critical reviews in food science and nutrition.

[3]  S. Chirumbolo,et al.  Plasma concentrations of the trace elements copper, zinc and selenium in Brazilian children with autism spectrum disorder. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[4]  M. Rahman,et al.  Toxic metal(loid)‐based pollutants and their possible role in autism spectrum disorder , 2018, Environmental research.

[5]  S. Chirumbolo,et al.  The Use of Multi-parametric Biomarker Profiles May Increase the Accuracy of ASD Prediction , 2018, Journal of Molecular Neuroscience.

[6]  F. Laurindo,et al.  Implications of plasma thiol redox in disease. , 2018, Clinical science.

[7]  S. Chirumbolo,et al.  Metabolism-Associated Markers and Childhood Autism Rating Scales (CARS) as a Measure of Autism Severity , 2018, Journal of Molecular Neuroscience.

[8]  S. Scherer,et al.  Progress in the genetics of autism spectrum disorder , 2018, Developmental medicine and child neurology.

[9]  S. Chirumbolo,et al.  Impaired lipid metabolism markers to assess the risk of neuroinflammation in autism spectrum disorder , 2018, Metabolic Brain Disease.

[10]  S. Chirumbolo,et al.  In the search for reliable biomarkers for the early diagnosis of autism spectrum disorder: the role of vitamin D , 2018, Metabolic Brain Disease.

[11]  S. Chirumbolo,et al.  Relationship between absolute and relative ratios of glutamate, glutamine and GABA and severity of autism spectrum disorder , 2018, Metabolic Brain Disease.

[12]  A. Holmgren,et al.  The role of the thioredoxin/thioredoxin reductase system in the metabolic syndrome: towards a possible prognostic marker? , 2018, Cellular and Molecular Life Sciences.

[13]  E. Susser,et al.  Prenatal fever and autism risk , 2017, Molecular Psychiatry.

[14]  Salvatore Chirumbolo,et al.  Cerebral hypoperfusion in autism spectrum disorder. , 2018, Acta neurobiologiae experimentalis.

[15]  Geir Bjorklund,et al.  Randomized controlled trial of vitamin D supplementation in children with autism spectrum disorder , 2018, Journal of child psychology and psychiatry, and allied disciplines.

[16]  M. Azeem,et al.  Use of N-Acetylcysteine in Psychiatric Conditions among Children and Adolescents: A Scoping Review , 2017, Cureus.

[17]  A. Vasquez.  Biological plausibility of the gut–brain axis in autism , 2017, Annals of the New York Academy of Sciences.

[18]  H. Stevens,et al.  The role of IL-6 in neurodevelopment after prenatal stress , 2017, Brain, Behavior, and Immunity.

[19]  M. Tremblay,et al.  Enkephalins: Endogenous Analgesics with an Emerging Role in Stress Resilience , 2017, Neural plasticity.

[20]  Geir Bjorklund,et al.  Assessment of gender and age effects on serum and hair trace element levels in children with autism spectrum disorder , 2017, Metabolic Brain Disease.

[21]  S. Chirumbolo,et al.  Tryptophan status in autism spectrum disorder and the influence of supplementation on its level , 2017, Metabolic Brain Disease.

[22]  S. Chirumbolo,et al.  Predictive value of selected biomarkers related to metabolism and oxidative stress in children with autism spectrum disorder , 2017, Metabolic Brain Disease.

[23]  S. Chirumbolo,et al.  The Role of Vitamin D in the Immune System as a Pro-survival Molecule. , 2017, Clinical therapeutics.

[24]  M. Chartrand,et al.  Manganese exposure and neurotoxic effects in children , 2017, Environmental research.

[25]  R. Bernier,et al.  Next Generation Sequencing Mitochondrial DNA Analysis in Autism Spectrum Disorder , 2017, Autism research : official journal of the International Society for Autism Research.

[26]  M. Chahrour,et al.  Candidate Genes for Inherited Autism Susceptibility in the Lebanese Population , 2017, Scientific Reports.

[27]  Geir Bjorklund,et al.  Relationship between selenium, lead, and mercury in red blood cells of Saudi autistic children , 2017, Metabolic Brain Disease.

[28]  Stephen J. Guter,et al.  Leveraging blood serotonin as an endophenotype to identify de novo and rare variants involved in autism , 2017, Molecular Autism.

[29]  S. J. James,et al.  Mathematical modeling of the methionine cycle and transsulfuration pathway in individuals with autism spectrum disorder. , 2017, Journal of theoretical biology.

[30]  N. Meguid,et al.  Expression of Reactive Oxygen Species–Related Transcripts in Egyptian Children With Autism , 2017, Biomarker insights.

[31]  Y. Goto,et al.  Associations of acute and chronic stress hormones with cognitive functions in autism spectrum disorder , 2017, Neuroscience.

[32]  Mira Park,et al.  Difference in mitochondrial DNA copy number in peripheral blood cells between probands with autism spectrum disorders and their unaffected siblings , 2017, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[33]  Wim E Crusio,et al.  Gene-Environment Interactions in Neurodevelopmental Disorders , 2017, Neural plasticity.

[34]  T. Borody,et al.  Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study , 2017, Microbiome.

[35]  E. Hsiao,et al.  Interactions between the microbiota, immune and nervous systems in health and disease , 2017, Nature Neuroscience.

[36]  Uwe Kruger,et al.  Significant Association of Urinary Toxic Metals and Autism-Related Symptoms—A Nonlinear Statistical Analysis with Cross Validation , 2017, PloS one.

[37]  A. Nasrat,et al.  Autism; An Approach for Definite Etiology and Definitive Etiologic Management , 2017 .

[38]  S. Chirumbolo,et al.  Role of oxidative stress and antioxidants in daily nutrition and human health. , 2017, Nutrition.

[39]  L. Croen,et al.  Association Between Influenza Infection and Vaccination During Pregnancy and Risk of Autism Spectrum Disorder , 2017, JAMA pediatrics.

[40]  Geir Bjorklund,et al.  Hair toxic and essential trace elements in children with autism spectrum disorder , 2017, Metabolic Brain Disease.

[41]  F. Beheshti,et al.  Protective Effect of PPARγ Agonists on Cerebellar Tissues Oxidative Damage in Hypothyroid Rats , 2016, Neurology research international.

[42]  B. Dale,et al.  Oxidative stress and alterations in DNA methylation: two sides of the same coin in reproduction. , 2016, Reproductive biomedicine online.

[43]  Vikas Kumar,et al.  Heavy metals (Pb, Cd, As and MeHg) as risk factors for cognitive dysfunction: A general review of metal mixture mechanism in brain. , 2016, Environmental toxicology and pharmacology.

[44]  M. Baumgartner,et al.  Autism in patients with propionic acidemia. , 2016, Molecular genetics and metabolism.

[45]  M. Ghaffari,et al.  Increased Serum Levels of Tumor Necrosis Factor-Alpha, Resistin, and Visfatin in the Children with Autism Spectrum Disorders: A Case-Control Study , 2016, Neurology research international.

[46]  J. Bressler,et al.  Role of Metabolic Genes in Blood Aluminum Concentrations of Jamaican Children with and without Autism Spectrum Disorder , 2016, International journal of environmental research and public health.

[47]  Mark H Johnson,et al.  Mitochondrial Dysfunction in Autism Spectrum Disorders. , 2016, Autism-open access.

[48]  Geir Bjorklund,et al.  Vitamin D status in autism spectrum disorders and the efficacy of vitamin D supplementation in autistic children , 2016, Nutritional neuroscience.

[49]  Lisa K. Sykes,et al.  The relationship between mercury and autism: A comprehensive review and discussion. , 2016, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.

[50]  G. Laviola,et al.  Genes and sex hormones interaction in neurodevelopmental disorders , 2016, Neuroscience & Biobehavioral Reviews.

[51]  P. McGuire,et al.  Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis , 2016, Psychiatry Research.

[52]  K. Schofield.  Autism, Chemicals, Probable Cause and Mitigation: A New Examination , 2016 .

[53]  N. Meguid,et al.  Altered urinary porphyrins and mercury exposure as biomarkers for autism severity in Egyptian children with autism spectrum disorder , 2016, Metabolic Brain Disease.

[54]  Geir Bjorklund,et al.  The positive association between elevated blood lead levels and brain-specific autoantibodies in autistic children from low lead-polluted areas , 2016, Metabolic Brain Disease.

[55]  Geir Bjorklund,et al.  Mercury as a possible link between maternal obesity and autism spectrum disorder. , 2016, Medical hypotheses.

[56]  J. Veenstra-VanderWeele,et al.  The serotonin system in autism spectrum disorder: From biomarker to animal models , 2016, Neuroscience.

[57]  Sarah Wong,et al.  Autism, Mitochondria and Polybrominated Diphenyl Ether Exposure. , 2016, CNS & neurological disorders drug targets.

[58]  H. Yamada,et al.  Oxidative Stress and Nitric Oxide in Autism Spectrum Disorder and Other Neuropsychiatric Disorders. , 2016, CNS & neurological disorders drug targets.

[59]  C. McDougle,et al.  A randomized placebo-controlled pilot study of N-acetylcysteine in youth with autism spectrum disorder , 2016, Molecular Autism.

[60]  Takeo Fujiwara,et al.  Chemicals, Nutrition, and Autism Spectrum Disorder: A Mini-Review , 2016, Front. Neurosci..

[61]  Jun Tan,et al.  The role of heparan sulfate deficiency in autistic phenotype: potential involvement of Slit/Robo/srGAPs-mediated dendritic spine formation , 2016, Neural Development.

[62]  Geir Bjorklund,et al.  Evaluation of whole blood zinc and copper levels in children with autism spectrum disorder , 2016, Metabolic Brain Disease.

[63]  A. El-Ansary.  Data of multiple regressions analysis between selected biomarkers related to glutamate excitotoxicity and oxidative stress in Saudi autistic patients , 2016, Data in brief.

[64]  A. Guastella,et al.  The effect of oxytocin nasal spray on social interaction deficits observed in young children with autism: a randomized clinical crossover trial , 2015, Molecular Psychiatry.

[65]  Salvatore Chirumbolo,et al.  Immune dysfunction and neuroinflammation in autism spectrum disorder. , 2016, Acta neurobiologiae experimentalis.

[66]  Geir Bjorklund,et al.  The levels of blood mercury and inflammatory-related neuropeptides in the serum are correlated in children with autism spectrum disorder , 2016, Metabolic Brain Disease.

[67]  S. Rombouts,et al.  White matter microstructure in a genetically defined group at increased risk of autism symptoms, and a comparison with idiopathic autism: an exploratory study , 2015, Brain Imaging and Behavior.

[68]  E. Fombonne,et al.  Obesity and Autism , 2015, Pediatrics.

[69]  Youhe Gao,et al.  Urinary Biomarkers of Brain Diseases , 2015, Genom. Proteom. Bioinform..

[70]  Yu Han,et al.  Abnormal transsulfuration metabolism and reduced antioxidant capacity in Chinese children with autism spectrum disorders , 2015, International Journal of Developmental Neuroscience.

[71]  J. Calderón,et al.  Increased homocysteine levels correlate with the communication deficit in children with autism spectrum disorder , 2015, Psychiatry Research.

[72]  R. Sothern,et al.  Measurement in saliva from neurotypical adults of biomarkers pertinent to autism spectrum disorders , 2015, Future science OA.

[73]  Geir Bjorklund,et al.  Acid glycosaminoglycan (aGAG) excretion is increased in children with autism spectrum disorder, and it can be controlled by diet , 2015, Metabolic Brain Disease.

[74]  A. Legido,et al.  Mitochondrial enzyme dysfunction in autism spectrum disorders; a novel biomarker revealed from buccal swab analysis. , 2015, Biomarkers in medicine.

[75]  Geir Bjorklund,et al.  A Randomized, Placebo-controlled Trial of Digestive Enzymes in Children with Autism Spectrum Disorders , 2015, Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology.

[76]  K. J. Parker,et al.  Arginine Vasopressin Is a Blood-Based Biomarker of Social Functioning in Children with Autism , 2015, PloS one.

[77]  D. Macfabe.  Enteric short-chain fatty acids: microbial messengers of metabolism, mitochondria, and mind: implications in autism spectrum disorders , 2015, Microbial ecology in health and disease.

[78]  Tewarit Sarachana,et al.  Investigation of sex differences in the expression of RORA and its transcriptional targets in the brain as a potential contributor to the sex bias in autism , 2015, Molecular Autism.

[79]  Chunlin Yan,et al.  Decreased plasma levels of lipoxin A4 in children with autism spectrum disorders , 2015, Neuroreport.

[80]  Jin-gang Fan,et al.  High plasma neopterin levels in Chinese children with autism spectrum disorders , 2015, International Journal of Developmental Neuroscience.

[81]  K. Xia,et al.  Elevated mitochondrial DNA copy number in peripheral blood cells is associated with childhood autism , 2015, BMC Psychiatry.

[82]  Hoda G. Hegazy,et al.  Interplay between pro-inflammatory cytokines and brain oxidative stress biomarkers: evidence of parallels between butyl paraben intoxication and the valproic acid brain physiopathology in autism rat model. , 2015, Cytokine.

[83]  Si-ju Gao,et al.  Thioredoxin: A novel, independent diagnosis marker in children with autism , 2015, International Journal of Developmental Neuroscience.

[84]  Xiaohong Li,et al.  Inflammatory Cytokines: Potential Biomarkers of Immunologic Dysfunction in Autism Spectrum Disorders , 2015, Mediators of inflammation.

[85]  Xiaolin Zhu,et al.  The combined role of serotonin and interleukin-6 as biomarker for autism , 2015, Neuroscience.

[86]  Geir Bjorklund,et al.  ADHD, autism and neuroradiological complications among phenylketonuric children in Upper Egypt , 2015, Acta Neurologica Belgica.

[87]  S Baron-Cohen,et al.  Elevated fetal steroidogenic activity in autism , 2014, Molecular Psychiatry.

[88]  Y. Ozkul,et al.  MTHFR Gene C677T Polymorphism in Autism Spectrum Disorders , 2014, Genetics research international.

[89]  Karl J. Friston,et al.  Neuroscience and Biobehavioral Reviews , 2014 .

[90]  Geir Bjorklund,et al.  Serum copper and zinc levels in individuals with autism spectrum disorders , 2014, Neuroreport.

[91]  Geir Bjørklund,et al.  Levels of Metals in the Blood and Specific Porphyrins in the Urine in Children with Autism Spectrum Disorders , 2014, Biological Trace Element Research.

[92]  Brian S. Hooker,et al.  A Dose-Response Relationship between Organic Mercury Exposure from Thimerosal-Containing Vaccines and Neurodevelopmental Disorders , 2014, International journal of environmental research and public health.

[93]  A. El-Ansary,et al.  Relative abundance of short chain and polyunsaturated fatty acids in propionic acid-induced autistic features in rat pups as potential markers in autism , 2014, Lipids in Health and Disease.

[94]  S. Walitza,et al.  Autism spectrum disorder associated with low serotonin in CSF and mutations in the SLC29A4 plasma membrane monoamine transporter (PMAT) gene , 2014, Molecular Autism.

[95]  Robert L. Hendren,et al.  Biomarkers in Autism , 2014, Front. Psychiatry.

[96]  Eric Boerwinkle,et al.  Role of Metabolic Genes in Blood Arsenic Concentrations of Jamaican Children with and without Autism Spectrum Disorder , 2014, International journal of environmental research and public health.

[97]  Sarabeth Broder-Fingert,et al.  Prevalence of overweight and obesity in a large clinical sample of children with autism. , 2014, Academic pediatrics.

[98]  S. Dimauro,et al.  Mitochondrial dysfunction as a neurobiological subtype of autism spectrum disorder: evidence from brain imaging. , 2014, JAMA psychiatry.

[99]  E. Susser,et al.  Parental Obesity and Risk of Autism Spectrum Disorder , 2014, Pediatrics.

[100]  F. El-baz,et al.  Study of plasma amino acid levels in children with autism: An Egyptian sample , 2014 .

[101]  S. J. James,et al.  Oxidative stress induces mitochondrial dysfunction in a subset of autistic lymphoblastoid cell lines , 2014, Translational Psychiatry.

[102]  E. Minikel,et al.  Autism Spectrum Disorder Genetics: Diverse Genes with Diverse Clinical Outcomes , 2014, Harvard review of psychiatry.

[103]  D. Rossignol,et al.  Environmental toxicants and autism spectrum disorders: a systematic review , 2014, Translational Psychiatry.

[104]  M. Valentovic,et al.  Transsulfuration Is a Significant Source of Sulfur for Glutathione Production in Human Mammary Epithelial Cells , 2013, ISRN biochemistry.

[105]  K. Jamil,et al.  Clinical Implications of MTHFR Gene Polymorphism in Various Diseases , 2014 .

[106]  T. Boeckers,et al.  Zinc deficiency dysregulates the synaptic ProSAP/Shank scaffold and might contribute to autism spectrum disorders. , 2014, Brain : a journal of neurology.

[107]  A. El-Ansary,et al.  Association of social and cognitive impairment and biomarkers in autism spectrum disorders , 2014, Journal of Neuroinflammation.

[108]  Hiroshi Yasuda,et al.  Assessment of Infantile Mineral Imbalances in Autism Spectrum Disorders (ASDs) , 2013, International journal of environmental research and public health.

[109]  R. Rose'meyer.  A review of the serotonin transporter and prenatal cortisol in the development of autism spectrum disorders , 2013, Molecular Autism.

[110]  J. Wegiel,et al.  Alterations in mitochondrial DNA copy number and the activities of electron transport chain complexes and pyruvate dehydrogenase in the frontal cortex from subjects with autism , 2013, Translational Psychiatry.

[111]  D. Siniscalco,et al.  Epigenetic Findings in Autism: New Perspectives for Therapy , 2013, International journal of environmental research and public health.

[112]  P. Gorrindo,et al.  Enrichment of Elevated Plasma F2t-Isoprostane Levels in Individuals with Autism Who Are Stratified by Presence of Gastrointestinal Dysfunction , 2013, PloS one.

[113]  P. Abruzzo,et al.  Oxidative Stress and Erythrocyte Membrane Alterations in Children with Autism: Correlation with Clinical Features , 2013, PloS one.

[114]  Francine Laden,et al.  Perinatal Air Pollutant Exposures and Autism Spectrum Disorder in the Children of Nurses’ Health Study II Participants , 2013, Environmental health perspectives.

[115]  M. Michalska,et al.  A focus on homocysteine in autism. , 2013, Acta biochimica Polonica.

[116]  E. Susser,et al.  Maternal folic acid supplementation and risk of autism--reply. , 2013, JAMA.

[117]  S. J. James,et al.  Redox metabolism abnormalities in autistic children associated with mitochondrial disease , 2013, Translational Psychiatry.

[118]  Huey-Miin Hsueh,et al.  The linear combinations of biomarkers which maximize the partial area under the ROC curves , 2013, Comput. Stat..

[119]  Jong H. Yoon,et al.  Oxytocin and Vasopressin in Children and Adolescents With Autism Spectrum Disorders: Sex Differences and Associations With Symptoms , 2013, Autism research : official journal of the International Society for Autism Research.

[120]  Robert Kumsta,et al.  Epigenetic regulation of the oxytocin receptor gene: implications for behavioral neuroscience , 2013, Front. Neurosci..

[121]  O. Brack,et al.  Distinct profiles of systemic biomarkers of oxidative stress in chronic human pathologies: Cardiovascular, psychiatric, neurodegenerative, rheumatic, infectious, neoplasmic and endocrinological diseases , 2013 .

[122]  A. Depino.  Peripheral and central inflammation in autism spectrum disorders , 2013, Molecular and Cellular Neuroscience.

[123]  Per Magnus,et al.  Association between maternal use of folic acid supplements and risk of autism spectrum disorders in children. , 2013, JAMA.

[124]  R. Frye,et al.  Unique acyl-carnitine profiles are potential biomarkers for acquired mitochondrial disease in autism spectrum disorder , 2013, Translational Psychiatry.

[125]  Geir Bjorklund,et al.  The role of zinc and copper in autism spectrum disorders. , 2013, Acta neurobiologiae experimentalis.

[126]  Lisa K. Sykes,et al.  Urinary Porphyrins in Autism Spectrum Disorders , 2013 .

[127]  A. El-Ansary,et al.  Neuroinflammation in autism spectrum disorders , 2012, Journal of Neuroinflammation.

[128]  F. Orio,et al.  Pervasive developmental disorders in children of hyperandrogenic women with polycystic ovary syndrome: a longitudinal case–control study , 2012, Clinical endocrinology.

[129]  D. Rosenberg,et al.  Mice Genetically Depleted of Brain Serotonin Display Social Impairments, Communication Deficits and Repetitive Behaviors: Possible Relevance to Autism , 2012, PloS one.

[130]  Stephanie Seneff,et al.  Impaired Sulfate Metabolism and Epigenetics: Is There a Link in Autism? , 2012, Entropy.

[131]  Marion Leboyer,et al.  Autism risk factors: genes, environment, and gene-environment interactions , 2012, Dialogues in clinical neuroscience.

[132]  K. Reichelt,et al.  Peptides’ role in autism with emphasis on exorphins , 2012, Microbial ecology in health and disease.

[133]  H. Chen,et al.  Application of LC-MS/MS analysis of plasma amino acids profiles in children with autism , 2012, Journal of clinical biochemistry and nutrition.

[134]  M. Hepel,et al.  Intervention of glutathione in pre-mutagenic catechol-mediated DNA damage in the presence of copper(II) ions. , 2012, Mutation research.

[135]  S. J. James,et al.  Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brain , 2012, Translational Psychiatry.

[136]  A. Sheikh,et al.  Brain IL-6 elevation causes neuronal circuitry imbalances and mediates autism-like behaviors. , 2012, Biochimica et biophysica acta.

[137]  Thomas Wisniewski,et al.  Abnormal Intracellular Accumulation and Extracellular Aβ Deposition in Idiopathic and Dup15q11.2-q13 Autism Spectrum Disorders , 2012, PloS one.

[138]  M. Fenech,et al.  The potential role of the antioxidant and detoxification properties of glutathione in autism spectrum disorders: a systematic review and meta-analysis , 2012, Nutrition & Metabolism.

[139]  D. Echeverria,et al.  Disordered Porphyrin Metabolism: A Potential Biological Marker for Autism Risk Assessment , 2012, Autism research : official journal of the International Society for Autism Research.

[140]  Jeremy Veenstra-VanderWeele,et al.  Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behavior , 2012, Proceedings of the National Academy of Sciences.

[141]  W. Gattaz,et al.  Altered Neurotrophin, Neuropeptide, Cytokines and Nitric Oxide Levels in Autism , 2012, Pharmacopsychiatry.

[142]  D. Gaylor,et al.  Metabolic Imbalance Associated with Methylation Dysregulation and Oxidative Damage in Children with Autism , 2012, Journal of autism and developmental disorders.

[143]  M. Kamboj,et al.  Role of endocrine factors in autistic spectrum disorders. , 2012, Pediatric clinics of North America.

[144]  D. Rossignol,et al.  Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis , 2011, Molecular Psychiatry.

[145]  P. Ashwood,et al.  Autism spectrum disorders: from immunity to behavior. , 2012, Methods in molecular biology.

[146]  K. Brady,et al.  Enhanced Cortisol Response to Stress in Children in Autism , 2011, Journal of Autism and Developmental Disorders.

[147]  Janet K. Kern,et al.  An evaluation of the role and treatment of elevated male hormones in autism spectrum disorders. , 2012, Acta neurobiologiae experimentalis.

[148]  H. Brenner,et al.  Neuregulin/ErbB regulate neuromuscular junction development by phosphorylation of α-dystrobrevin , 2011, The Journal of cell biology.

[149]  Janet K. Kern,et al.  A clinical trial of glutathione supplementation in autism spectrum disorders , 2011, Medical science monitor : international medical journal of experimental and clinical research.

[150]  A. El-Ansary,et al.  Novel metabolic biomarkers related to sulfur-dependent detoxification pathways in autistic patients of Saudi Arabia , 2011, BMC neurology.

[151]  S. Viville,et al.  Autism, imprinting and epigenetic disorders: a metabolic syndrome linked to anomalies in homocysteine recycling starting in early life?? , 2011, Journal of Assisted Reproduction and Genetics.

[152]  R. Perlis,et al.  Translating biomarkers to clinical practice , 2011, Molecular Psychiatry.

[153]  M. Angley,et al.  A review of candidate urinary biomarkers for autism spectrum disorder , 2011, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[154]  A. El-Ansary,et al.  Proinflammatory and proapoptotic markers in relation to mono and di-cations in plasma of autistic patients from Saudi Arabia , 2011, Journal of Neuroinflammation.

[155]  Lakshmi Priya Malarveni Damodaran,et al.  Urinary oxidative stress markers in children with autism , 2011, Redox report : communications in free radical research.

[156]  A. Bacha,et al.  Relationship between chronic lead toxicity and plasma neurotransmitters in autistic patients from Saudi Arabia. , 2011, Clinical biochemistry.

[157]  I. Cohen,et al.  Population- and Family-Based Studies Associate the MTHFR Gene with Idiopathic Autism in Simplex Families , 2011, Journal of autism and developmental disorders.

[158]  David Quig,et al.  Nutritional and metabolic status of children with autism vs. neurotypical children, and the association with autism severity , 2011, Nutrition & metabolism.

[159]  V. Eapen.  Genetic basis of autism: is there a way forward? , 2011, Current opinion in psychiatry.

[160]  A. El-Ansary,et al.  Impaired plasma phospholipids and relative amounts of essential polyunsaturated fatty acids in autistic patients from Saudi Arabia , 2011, Lipids in Health and Disease.

[161]  J. Wegiel,et al.  Brain region‐specific deficit in mitochondrial electron transport chain complexes in children with autism , 2011, Journal of neurochemistry.

[162]  M. Hepel,et al.  Antioxidant Effectiveness in Preventing Paraquat-Mediated Oxidative DNA Damage in the Presence of H2O2 , 2011 .

[163]  N. Meguid,et al.  Evaluation of Oxidative Stress in Autism: Defective Antioxidant Enzymes and Increased Lipid Peroxidation , 2011, Biological Trace Element Research.

[164]  J. Sutcliffe,et al.  Association of oxytocin receptor (OXTR) gene variants with multiple phenotype domains of autism spectrum disorder , 2011, Journal of Neurodevelopmental Disorders.

[165]  R. Dubner,et al.  Interactions between the immune and nervous systems in pain , 2010, Nature Medicine.

[166]  M. Hepel,et al.  Interactions of Herbicide Atrazine With DNA , 2010 .

[167]  R. Mckinnon,et al.  Is there a role for routinely screening children with autism spectrum disorder for creatine deficiency syndrome? , 2010, Autism research : official journal of the International Society for Autism Research.

[168]  R. Reading,et al.  Clinical genetic testing for patients with autism spectrum disorders , 2010 .

[169]  D. Echeverria,et al.  Urinary Porphyrin Excretion in Neurotypical and Autistic Children , 2010, Environmental health perspectives.

[170]  M. Fenech,et al.  Folate and methionine metabolism in autism: a systematic review. , 2010, The American journal of clinical nutrition.

[171]  Erik T Parner,et al.  Maternal Infection Requiring Hospitalization During Pregnancy and Autism Spectrum Disorders , 2010, Journal of autism and developmental disorders.

[172]  J. Prandota.  Neuropathological changes and clinical features of autism spectrum disorder participants are similar to that reported in congenital and chronic cerebral toxoplasmosis in humans and mice , 2010 .

[173]  Sharyn A. Lincoln,et al.  Clinical Genetic Testing for Patients With Autism Spectrum Disorders , 2010, Pediatrics.

[174]  Per Magnus,et al.  THE AUTISM BIRTH COHORT (ABC): A PARADIGM FOR GENE-ENVIRONMENT-TIMING RESEARCH , 2010, Molecular Psychiatry.

[175]  A. El-Ansary,et al.  Metabolic biomarkers related to oxidative stress and antioxidant status in Saudi autistic children. , 2009, Clinical biochemistry.

[176]  D. Zafeiriou,et al.  The Serotonergic System: Its Role in Pathogenesis and Early Developmental Treatment of Autism , 2009, Current neuropharmacology.

[177]  H. M. Skip Kingston,et al.  The plasma zinc/serum copper ratio as a biomarker in children with autism spectrum disorders , 2009, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[178]  Sangita B. Patil,et al.  Elevated immune response in the brain of autistic patients , 2009, Journal of Neuroimmunology.

[179]  A. Kobal.  Possible influence of mercury on pathogenesis of autism. , 2009 .

[180]  D. Winge,et al.  “ Pulling the plug ” on cellular copper : The role of mitochondria in copper export , 2008 .

[181]  J. Kern,et al.  A Prospective Study of Transsulfuration Biomarkers in Autistic Disorders , 2009, Neurochemical Research.

[182]  Janet K. Kern,et al.  A Prospective Study of Transsulfuration Biomarkers in Autistic Disorders , 2009, Neurochemical Research.

[183]  Bruce H. Cohen,et al.  Mitochondrial Disease in Autism Spectrum Disorder Patients: A Cohort Analysis , 2008, PloS one.

[184]  Kjetil Søreide,et al.  Receiver-operating characteristic curve analysis in diagnostic, prognostic and predictive biomarker research , 2008, Journal of Clinical Pathology.

[185]  E. Rogers.  Has enhanced folate status during pregnancy altered natural selection and possibly Autism prevalence? A closer look at a possible link. , 2008, Medical hypotheses.

[186]  P. Moretti,et al.  Brief Report: Autistic Symptoms, Developmental Regression, Mental Retardation, Epilepsy, and Dyskinesias in CNS Folate Deficiency , 2008, Journal of autism and developmental disorders.

[187]  Nenad Blau,et al.  A milk‐free diet downregulates folate receptor autoimmunity in cerebral folate deficiency syndrome , 2008, Developmental medicine and child neurology.

[188]  G. B. Schaefer,et al.  Clinical genetics evaluation in identifying the etiology of autism spectrum disorders , 2008, Genetics in Medicine.

[189]  Paolo Curatolo,et al.  Autism and Metabolic Diseases , 2008, Journal of child neurology.

[190]  R. Deth,et al.  How environmental and genetic factors combine to cause autism: A redox/methylation hypothesis. , 2008, Neurotoxicology.

[191]  N. Blau,et al.  Folate receptor autoimmunity and cerebral folate deficiency in low-functioning autism with neurological deficits. , 2007, Neuropediatrics.

[192]  David A Geier,et al.  A prospective assessment of androgen levels in patients with autistic spectrum disorders: biochemical underpinnings and suggested therapies. , 2007, Neuro endocrinology letters.

[193]  M. Chez,et al.  Elevation of tumor necrosis factor-alpha in cerebrospinal fluid of autistic children. , 2007, Pediatric neurology.

[194]  C. Sala,et al.  DNA methylation regulates tissue‐specific expression of Shank3 , 2007, Journal of neurochemistry.

[195]  M. Noble,et al.  Chemically Diverse Toxicants Converge on Fyn and c-Cbl to Disrupt Precursor Cell Function , 2007, PLoS biology.

[196]  Simon Gilbody,et al.  Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review. , 2006, American journal of epidemiology.

[197]  Jun-Ming Zhang,et al.  Cytokines, Inflammation, and Pain , 2007, International anesthesiology clinics.

[198]  A. Holmgren,et al.  Thioredoxin and related molecules--from biology to health and disease. , 2007, Antioxidants & redox signaling.

[199]  J. Pincemail,et al.  [Oxidative stress]. , 2007, Revue medicale de Liege.

[200]  P. Landrigan,et al.  Developmental neurotoxicity of industrial chemicals , 2006, The Lancet.

[201]  A. Chauhan,et al.  Oxidative stress in autism. , 2006, Pathophysiology : the official journal of the International Society for Pathophysiology.

[202]  Nathalie Boddaert,et al.  Autism, the superior temporal sulcus and social perception , 2006, Trends in Neurosciences.

[203]  F. George,et al.  Analyses of toxic metals and essential minerals in the hair of arizona children with autism and associated conditions, and their mothers , 2006, Biological Trace Element Research.

[204]  L. López-Carrillo,et al.  Methylenetetrahydrofolate reductase 677C>T polymorphism and gastric cancer susceptibility in Mexico. , 2006, European journal of cancer.

[205]  Janet K. Kern,et al.  Evidence of Toxicity, Oxidative Stress, and Neuronal Insult in Autism , 2006, Journal of toxicology and environmental health. Part B, Critical reviews.

[206]  Eric E. Schadt,et al.  Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice , 2005, Nature.

[207]  T P Stein,et al.  Increased excretion of a lipid peroxidation biomarker in autism. , 2005, Prostaglandins, leukotrienes, and essential fatty acids.

[208]  Nenad Blau,et al.  Autoantibodies to folate receptors in the cerebral folate deficiency syndrome. , 2005, The New England journal of medicine.

[209]  R. Finnell,et al.  Cerebral folate deficiency with developmental delay, autism, and response to folinic acid , 2005, Neurology.

[210]  G. Oliveira,et al.  Mitochondrial dysfunction in autism spectrum disorders: a population-based study. , 2005, Developmental medicine and child neurology.

[211]  Samantha A. Stewart.  The effects of benzodiazepines on cognition. , 2005, The Journal of clinical psychiatry.

[212]  A. Zimmerman,et al.  Neuroglial activation and neuroinflammation in the brain of patients with autism , 2005, Annals of neurology.

[213]  C. McDougle,et al.  Neurochemistry in the pathophysiology of autism. , 2005, The Journal of clinical psychiatry.

[214]  N. Blau,et al.  Cerebral folate deficiency , 2004, Developmental medicine and child neurology.

[215]  David W Gaylor,et al.  Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. , 2004, The American journal of clinical nutrition.

[216]  C. Costa,et al.  Zinc/copper imbalance reflects immune dysfunction in human leishmaniasis: an ex vivo and in vitro study , 2004, BMC infectious diseases.

[217]  W. Brown,et al.  Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin--the antioxidant proteins. , 2004, Life sciences.

[218]  C. F. Fischer Walker,et al.  Zinc and the risk for infectious disease. , 2004, Annual review of nutrition.

[219]  S. Zoroglu,et al.  Increased oxidative stress and altered activities of erythrocyte free radical scavenging enzymes in autism , 2004, European Archives of Psychiatry and Clinical Neuroscience.

[220]  C. McDougle,et al.  High nitric oxide production in autistic disorder: a possible role for interferon-γ , 2004, Biological Psychiatry.

[221]  I L Cohen,et al.  Association of autism severity with a monoamine oxidase A functional polymorphism , 2003, Clinical genetics.

[222]  H. Savaş,et al.  Changes in nitric oxide levels and antioxidant enzyme activities may have a role in the pathophysiological mechanisms involved in autism. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[223]  C. Marini,et al.  Urinary Nitric Oxide Metabolites and Lipid Peroxidation By-Products in Migraine , 2003, Cephalalgia : an international journal of headache.

[224]  N. Blau,et al.  Psychomotor retardation, spastic paraplegia, cerebellar ataxia and dyskinesia associated with low 5-methyltetrahydrofolate in cerebrospinal fluid: a novel neurometabolic condition responding to folinic acid substitution. , 2003, Neuropediatrics.

[225]  O. Yorbik,et al.  Investigation of antioxidant enzymes in children with autistic disorder. , 2002, Prostaglandins, leukotrienes, and essential fatty acids.

[226]  E. Anyanwu,et al.  Antibodies to neuron-specific antigens in children with autism: possible cross-reaction with encephalitogenic proteins from milk, Chlamydia pneumoniae and Streptococcus group A , 2002, Journal of Neuroimmunology.

[227]  G. Bing,et al.  Oxidative damage causes formation of lipofuscin-like substances in the hippocampus of the senescence-accelerated mouse after kainate treatment , 2002, Behavioural Brain Research.

[228]  J. Yodoi,et al.  Thioredoxin as a biomarker for oxidative stress in patients with rheumatoid arthritis. , 2002, Molecular immunology.

[229]  A. Hardan,et al.  A retrospective open trial of adjunctive donepezil in children and adolescents with autistic disorder. , 2002, Journal of child and adolescent psychopharmacology.

[230]  T. Kemper,et al.  Density and Distribution of Hippocampal Neurotransmitter Receptors in Autism: An Autoradiographic Study , 2001, Journal of autism and developmental disorders.

[231]  E K Perry,et al.  Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain. , 2001, The American journal of psychiatry.

[232]  A. Nunomura,et al.  Mitochondrial abnormalities in Alzheimer disease , 2000, Neurobiology of Aging.

[233]  W. Streit,et al.  Microglial Response to Brain Injury: A Brief Synopsis , 2000, Toxicologic pathology.

[234]  J. Papadimitriou,et al.  Gastrointestinal abnormalities in children with autistic disorder. , 1999, The Journal of pediatrics.

[235]  J. Cravedi,et al.  Identification of novel urinary metabolites of the lipid peroxidation product 4-hydroxy-2-nonenal in rats. , 1998, Chemical research in toxicology.

[236]  J. Truman,et al.  Nitric oxide-sensitive guanylate cyclase activity is associated with the maturational phase of neuronal development in insects. , 1996, Development.

[237]  J. Yodoi,et al.  A novel promoter sequence is involved in the oxidative stress-induced expression of the adult T-cell leukemia-derived factor (ADF)/human thioredoxin (Trx) gene. , 1996, Nucleic acids research.

[238]  M. Roederer,et al.  Elevation of plasma thioredoxin levels in HIV-infected individuals. , 1996, International immunology.

[239]  F. Barone,et al.  Cytokines, inflammation, and brain injury: role of tumor necrosis factor-alpha. , 1994, Cerebrovascular and brain metabolism reviews.

[240]  S. Rose,et al.  An inhibitor of nitric oxide synthesis prevents memory formation in the chick , 1992, Neuroscience Letters.

[241]  K. Johnson,et al.  Nitric oxide induces neurotransmitter release from hippocampal slices. , 1992, European journal of pharmacology.

[242]  Mitchell H. Gail,et al.  A family of nonparametric statistics for comparing diagnostic markers with paired or unpaired data , 1989 .

[243]  J. Hibbs,et al.  Nitric oxide: a cytotoxic activated macrophage effector molecule. , 1988, Biochemical and biophysical research communications.

[244]  C. Metz.  ROC Methodology in Radiologic Imaging , 1986, Investigative radiology.

[245]  J. Swets.  Indices of discrimination or diagnostic accuracy: their ROCs and implied models. , 1986, Psychological bulletin.

[246]  J. Swets.  ROC analysis applied to the evaluation of medical imaging techniques. , 1979, Investigative radiology.

[247]  T. Buckler.  Art. X.—On the Use of the Phosphate of Ammonia, as a new remedy for Gout and Rheumatism, as a solvent of uric acid calculus, and for diseases, acute and chronic, connected directly with the lithic acid diathesis. , 1846 .